Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations.
Gisondi P, Talamonti M, Chiricozzi A, Piaserico S, Amerio P, Balato A, Bardazzi F, Calzavara Pinton P, Campanati A, Cattaneo A, Dapavo P, De Simone C, Dini V, Fargnoli MC, Flori ML, Galluzzo M, Guarneri C, Lasagni C, Loconsole F, Lo Schiavo A, Malagoli P, Malara G, Mercuri SR, Musumeci ML, Naldi L, Papini M, Parodi A, Potenza C, Prignano F, Rongioletti F, Stingeni L, Tiberio R, Venturini M, Bianchi L, Costanzo A, Cusano F, Girolomoni G, Offidani AM, Peris K. Gisondi P, et al. Among authors: offidani am. Dermatol Ther (Heidelb). 2021 Feb;11(1):235-252. doi: 10.1007/s13555-020-00475-8. Epub 2021 Jan 11. Dermatol Ther (Heidelb). 2021. PMID: 33426634 Free PMC article.
Effectiveness of etanercept in children with plaque psoriasis in real practice: a one-year multicenter retrospective study.
Di Lernia V, Guarneri C, Stingeni L, Gisondi P, Bonamonte D, Calzavara Pinton PG, Offidani A, Hansel K, Girolomoni G, Filoni A, Belloni Fortina A, Ficarelli E, Cannavò SP. Di Lernia V, et al. J Dermatolog Treat. 2018 May;29(3):217-219. doi: 10.1080/09546634.2017.1364692. Epub 2017 Aug 18. J Dermatolog Treat. 2018. PMID: 28783991 Clinical Trial.
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience.
Conti A, Peccerillo F, Amerio P, Balato A, Bardazzi F, Bianchi L, Burlando M, Cannavò SP, Chiricozzi A, Dapavo P, De Simone C, Fargnoli MC, Gambardella A, Gisondi P, Malagoli P, Malara G, Mugheddu C, Offidani AM, Piaserico S, Prignano F, Stingeni L, Pellacani G. Conti A, et al. Among authors: offidani am. Br J Dermatol. 2019 Jun;180(6):1547-1548. doi: 10.1111/bjd.17580. Epub 2019 Feb 21. Br J Dermatol. 2019. PMID: 30578668 No abstract available.
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience.
Fargnoli MC, Esposito M, Dapavo P, Parodi A, Rossi M, Tiberio R, Dastoli S, Offidani AM, Argenziano G, Gisondi P, Lo Schiavo A, Loconsole F, Pella P, Bardazzi F, Cusano F, Gattoni M, Nacca M, Cannavò SP, Pellegrini C, Costanzo A; BRILLIANT Working Group. Fargnoli MC, et al. Among authors: offidani am. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):693-700. doi: 10.1111/jdv.16931. Epub 2020 Oct 13. J Eur Acad Dermatol Venereol. 2021. PMID: 32916767
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore.
Marzano AV, Chiricozzi A, Giovanardi G, Argenziano G, Bettoli V, Bianchi L, Dapavo P, Dini V, Fabbrocini G, Micali G, Offidani AM, Potenza C, Prignano F, Gualberti G, Saragaglia V, Rongioletti F. Marzano AV, et al. Among authors: offidani am. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1815-1821. doi: 10.1111/jdv.16328. Epub 2020 May 12. J Eur Acad Dermatol Venereol. 2020. PMID: 32119143 Free PMC article.
Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort.
Bianchi L, Caposiena Caro RD, Ganzetti G, Molinelli E, Dini V, Oranges T, Romanelli M, Fabbrocini G, Monfrecola G, Napolitano M, Egan CG, Musumeci ML, Lacarrubba F, Micali G, Passoni E, Calzavara-Pinton PG, Venturini M, Zanca A, Offidani AM. Bianchi L, et al. Among authors: offidani am. Clin Exp Dermatol. 2019 Jul;44(5):e177-e180. doi: 10.1111/ced.13861. Epub 2018 Dec 28. Clin Exp Dermatol. 2019. PMID: 30593710
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group.
Napolitano M, Calzavara-Pinton PG, Zanca A, Bianchi L, Caposiena Caro RD, Offidani AM, Ganzetti G, Molinelli E, Dini V, Oranges T, Romanelli M, Egan CG, Fabbrocini G, Monfrecola G, Lacarrubba F, Musumeci ML, Passoni E, Venturini M, Micali G. Napolitano M, et al. Among authors: offidani am. J Eur Acad Dermatol Venereol. 2019 Feb;33(2):e84-e87. doi: 10.1111/jdv.15235. Epub 2018 Sep 25. J Eur Acad Dermatol Venereol. 2019. PMID: 30176092 No abstract available.
Secukinumab in multi-failure psoriatic patients: the last hope?
Magnano M, Loi C, Patrizi A, Sgubbi P, Balestri R, Rech G, Tasin L, Girardelli CR, Conti A, Odorici G, Campanati A, Offidani AM, Bardazzi F. Magnano M, et al. Among authors: offidani am. J Dermatolog Treat. 2018 Sep;29(6):583-585. doi: 10.1080/09546634.2018.1427206. Epub 2018 Jan 23. J Dermatolog Treat. 2018. PMID: 29334270
MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab.
Mensà E, Recchioni R, Marcheselli F, Giuliodori K, Consales V, Molinelli E, Prattichizzo F, Rippo MR, Campanati A, Procopio AD, Olivieri F, Offidani AM. Mensà E, et al. Among authors: offidani am. Br J Dermatol. 2018 Sep;179(3):787-789. doi: 10.1111/bjd.16659. Epub 2018 Aug 20. Br J Dermatol. 2018. PMID: 29624637 Clinical Trial. No abstract available.
63 results